Email ID
Password
OSI Pharmaceuticals ' board has unanimously rejected Astellas 's unsolicited $52 per share cash offer for the company, recommending that OSI shareholders do ...
Hypolipaemic fenofibrates such as Abbott s' TriCor, its next-generation Trilipix and generics, do not improve cardiovascular outcomes in patients with type 2 ...
Bristol-Myers Squibb and Sanofi-Aventis have added a "boxed warning" to the US label for the blockbuster blood thinner Plavix (clopidogrel), in order to warn ...
Pfizer is facing more disappointment with the development of some of its most advanced anticancers after Sutent (sunitinib) failed two more Phase III trials in ...
 
Promedior has raised $12 million in a series C financing round. The clinical-stage US biotechnology company is developing therapies to treat inflammatory and fibrotic diseases. Forbion Capital ...
Lilly is to pay Acrux $50 million up front for the global commercialisation rights to its underarm testosterone solution Axiron. The Australian company will also receive $3 million in the transfer of ...
Belgian antibody firm Ablynx has completed its secondary public offering, raising €50 million through the sale of just under 6.7 million new shares at €7.50 each. An over-allotment option of up to ...
Grindeks of Latvia has signed an agreement with the national investment and development agency, under which it will receive funding of Ls2.8 million ($5.4 million) from the European Regional ...
 
Amylin Pharmaceuticals , Lilly and Alkermes ' type 2 diabetes candidate Bydureon (exenatide for extended-release injectable suspension) – a once-weekly formulation of the twice-daily dosed Byetta – ...
The US FDA was established in 1931, but only three years ago did it get the power to order drug makers to conduct safety studies of products that have already been approved and put into general use. ...
The US FDA has issued Actelion with a complete response letter for its drug Zavesca (miglustat), for the treatment of progressive neurological manifestations in adults and children with Niemann-Pick ...
Takara Bio has signed a collaborative research agreement with the University of Pennsylvania in the US for the co-development of an innovative gene-based therapy for HIV. The Japanese firm will work ...
 
Ranbaxy Laboratories has settled outstanding patent litigation with Takeda Pharmaceutical Company , allowing it to launch a generic version of Takeda's antidiabetic, Actos (pioglitazone ...
NICE , the health technology appraisal body for England and Wales, has given a preliminary green light to treating some psoriatic arthritis patients with Abbott 's Humira (adalimumab) and Wyeth 's ...
The R&D industry association Medicines Australia is donating A$1 million ($912,997), collected in fines from pharmaceutical companies that breached the marketing code of conduct, to a charity aimed ...
Germany's health ministry is planning to introduce compulsory price negotiations for patented drugs between the pharmaceutical industry and health insurers, it confirmed to Scrip. The measure could ...
 
Two new appointments at Cerulean Pharma Cerulean Pharma, a US biopharmaceutical company focused on nanoparticle-based drugs, has appointed ...
New president for Sandoz's US operations Sandoz , the generics arm of Novartis, has named Don DeGolyer president of US operations and head ...
New appointment as UK pharmacy regulator demerger approaches Preparations for thedemerging of the Royal Pharmaceutical Society of Great Britain (RPSGB) are ...

The fact that many poor countries globally suffer as a result of the lack of access to life-saving ...

Market Insight: Big pharma hit by Greece's fiscal crisis
09 March 2010

Hospitals' failure to pay pharmaceutical companies and newly announced price cuts are just some of ...

 Market Insight - Fear gives way to prudence a...

How to run clinical trials in the Middle East - why the GCC?
04 March 2010

A grouping of Middle Eastern countries came together under the auspices of the Gulf Co-operation ...

How to run clinical trials in the Middle East - Jordan
04 March 2010

Jordan has a population of 6.35 million and its GDP per capita is $5,000, while its healthcare ...

Private investment round-up: February 2010
15 March 2010
Simon Varcoe
Just as it appeared that the private investment market was beginning to rebound after last year's ...

Logos are said to be an important part of an organisation's branding. Really good logos contribute ...

Jeff George took over as head of Sandoz, Novartis's generics business, in late 2008. With a big ...

CPhI Worldwide 2009
13 October 2009
Scrip's official preview of CPhI Worldwide, ICSE, P-MEC and BioPh 2009

Scrip's Stock Tracker February 2010
12 March 2010
Ashley Yeo
Talk of dividends being under threat at companies such as Bristol-Myers Squibb , Pfizer and Lilly , ...

JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36